共 50 条
- [1] Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (06): : 1052 - 1061
- [5] Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan Clinical and Experimental Nephrology, 2015, 19 : 746 - 752
- [7] Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement A Randomized Clinical Trial CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (09): : 1267 - 1278
- [9] Concurrent Targeting of Vasopressin Receptor 2 and Somatostatin Receptors in Autosomal Dominant Polycystic Kidney Disease: A Promising Approach for Autosomal Dominant Polycystic Kidney Disease Treatment? CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (02): : 154 - 156